TR199501082A2 - Farmasötik formülasyonlar. - Google Patents

Farmasötik formülasyonlar.

Info

Publication number: TR199501082A2
Authority: TR; Turkey
Prior art keywords: pharmaceutical formulations; formulations; pharmaceutical
Prior art date: 1994-09-03

Application number

TR95/01082A

Other languages

English (en)

Turkish (tr)

Inventor

Patrick John Crowley

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-03

Filing date

1995-08-31

Publication date

1996-06-21

1994-09-03 Priority claimed from GB9417953A external-priority patent/GB9417953D0/en

1995-02-24 Priority claimed from GBGB9503752.9A external-priority patent/GB9503752D0/en

1995-08-31 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1996-06-21 Publication of TR199501082A2 publication Critical patent/TR199501082A2/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

TR95/01082A 1994-09-03 1995-08-31 Farmasötik formülasyonlar. TR199501082A2 (tr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9417953A GB9417953D0 (en)	1994-09-03	1994-09-03	Pharmaceutical formulations
GBGB9503752.9A GB9503752D0 (en)	1995-02-24	1995-02-24	Pharmaceutical formulations
US46044195A	1995-06-02	1995-06-02

Publications (1)

Publication Number	Publication Date
TR199501082A2 true TR199501082A2 (tr)	1996-06-21

Family

ID=27267365

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TR95/01082A TR199501082A2 (tr)	1994-09-03	1995-08-31	Farmasötik formülasyonlar.

Country Status (8)

Country	Link
EP (1)	EP0782443A1 (fr)
JP (1)	JPH10505595A (fr)
AU (1)	AU3471995A (fr)
DZ (1)	DZ1926A1 (fr)
IL (1)	IL115125A0 (fr)
MA (1)	MA23663A1 (fr)
TR (1)	TR199501082A2 (fr)
WO (1)	WO1996007408A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0862431T3 (da)	1995-09-07	2002-03-11	Smithkline Beecham Plc	Anvendelse af pædiatrisk farmaceutisk formulering omfattende amoxycillin og clavulanat
SK110299A3 (en) *	1997-02-14	2000-08-14	Smithkline Beecham Lab	Pharmaceutical formulations comprising amoxocyllin and clavulanate, preparation method and use thereof
US6706290B1 (en)	1998-07-06	2004-03-16	Olvai E. Kajander	Methods for eradication of nanobacteria
ATE282959T1 (de) *	1998-07-06	2004-12-15	Nanobac Oy	Verfahren zur beseitigung von nanobakterien
US6294199B1 (en)	1999-04-13	2001-09-25	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en)	1999-04-13	2007-07-31	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection
US6878386B1 (en)	1999-04-13	2005-04-12	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
AU2001292185A1 (en)	2000-10-12	2002-04-22	Beecham Pharmaceuticals (Pte) Limited	Formulation containing amoxicillin
US6756057B2 (en)	2000-10-12	2004-06-29	Beecham Pharmaceuticals (Pte) Limited	Amoxicillin and potassium clavulanate dosage form
US8614315B2 (en) *	2009-12-25	2013-12-24	Mahmut Bilgic	Cefdinir and cefixime formulations and uses thereof
TR201000688A2 (tr)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
EP2575782A2 (fr) *	2010-06-03	2013-04-10	Mahmut Bilgic	Formulations effervescentes comprenant de la céphalosporine et de l'acide clavulcanique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2861607D1 (en) *	1977-11-26	1982-03-11	Beecham Group Plc	Derivatives of clavulanic acid and pharmaceutical compositions containing them
NZ198241A (en) *	1980-09-27	1983-12-16	Beecham Group Ltd	Tablet containing amoxycillin and potassium clavulanate
EP1034784A3 (fr) *	1993-01-22	2001-06-27	Smithkline Beecham Plc	Formulations pharmaceutique contenant d'acide clavulanique et un agent antibacterien

1995
- 1995-08-02 DZ DZ950107A patent/DZ1926A1/fr active
- 1995-08-21 AU AU34719/95A patent/AU3471995A/en not_active Abandoned
- 1995-08-21 WO PCT/EP1995/003322 patent/WO1996007408A1/fr not_active Ceased
- 1995-08-21 EP EP95931176A patent/EP0782443A1/fr not_active Withdrawn
- 1995-08-21 JP JP8509160A patent/JPH10505595A/ja not_active Ceased
- 1995-08-31 TR TR95/01082A patent/TR199501082A2/xx unknown
- 1995-09-01 MA MA24005A patent/MA23663A1/fr unknown
- 1995-09-01 IL IL11512595A patent/IL115125A0/xx unknown

Also Published As

Publication number	Publication date
JPH10505595A (ja)	1998-06-02
WO1996007408A1 (fr)	1996-03-14
AU3471995A (en)	1996-03-27
MA23663A1 (fr)	1996-04-01
EP0782443A1 (fr)	1997-07-09
IL115125A0 (en)	1995-12-31
DZ1926A1 (fr)	2002-02-17

Publication	Publication Date	Title
BR9610153A (pt)	1999-01-05	Formulações farmacêuticas
BR9611626A (pt)	1999-06-01	Formulações farmacéuticas
TR199901077A3 (tr)	1999-12-21	Ispençiyari formülasyonlar.
FI20071025L (fi)	2007-12-28	Farmaseuttisia koostumuksia
DE69530325D1 (de)	2003-05-15	Aerosol-arzneiformulierungen
FI971279A0 (fi)	1997-03-26	Lääkkeitä
NO954486D0 (no)	1995-11-08	Farmasöytiske formuleringsgrunnlag
DZ2026A1 (fr)	2002-07-21	Compositions vaccinantes.
DZ2055A1 (fr)	2002-10-20	Compositions vaccinantes.
DZ1835A1 (fr)	2002-02-17	Nouvelles formulations.
DE69524185D1 (de)	2002-01-10	Zwei-walzen-giessverfahren
ID16781A (id)	1997-11-13	Formulasi-formulasi farmasi
DZ1926A1 (fr)	2002-02-17	Formulations pharmaceutiques.
ITMI941169A0 (it)	1994-06-06	Formulazioni farmaceutiche
BR9507768A (pt)	1997-09-02	Composição farmacêutica
EP0837863A4 (fr)	1999-06-16	Preparations d'alendronate disodique
ITMI942166A0 (it)	1994-10-21	Composizioni farmaceutiche miorilassanti
FI951155A7 (fi)	1995-09-15	Farmaseuttinen valmiste
TR199601018A1 (tr)	1997-07-21	Farmasötik bilesikler.
FI962738A0 (fi)	1996-07-03	Farmaseuttiset koostumukset
FI954050L (fi)	1996-03-02	Lääkekoostumuksia
FI934317A0 (fi)	1993-10-01	Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
TR199500776A2 (tr)	1996-06-21	Farmasötik bilesimler.
SE9404467D0 (sv)	1994-12-22	Drug formulations
SE9502453D0 (sv)	1995-07-06	Drug formulations